External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience CMSC 2026
Roche and Genentech at

CMSC 2026

May 27 - May 29
Charlotte, USA
cmscscholar.org
We will be contributing to topics related to
Neuroscience
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
07:00 PM
Duration 120mins Charlotte, USA
A Decade of Pregnancy Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Over 5000 Pregnancies
Kristne Krysko, Ruth Dobson, Sandra Vukusic, Kerstin Hellwig, Celia Oreja-Guevara, Carlo Pietrasanta, T McElrath, Agne Kazlauskaite, Germano Ferreira, Daniela Alves, Yuliang He, Chien-Ju Lin, Noemi Pasquarelli, Riley Bove
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, NC
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Nicholas, Jacqueline A.; Bar-Or, Amit; Oh, Jiwon; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; von Büdingen, Hans-Christian; Lopez, Jon; Roberts, Louise; Triyatni, Miriam; Qi, Qi; Ratchford, John N.; Napieralski, Julie; Goodyear, Alexandra; Hauser, Stephen L.; Kappos, Ludwig
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 PM
Duration 120mins Charlotte, USA
No Evidence of Disease Activity on Intravenous or Subcutaneous Ocrelizumab in Treatment-Naive Relapsing Multiple Sclerosis in the OPERA (10 Yrs) and OCARINA II (2 Yrs) Trials
Newsome, Scott D., Cerqueira, João; Centonze, Diego; Traboulsee, Anthony; Craveiro, Licinio; Schenble, Hans-Martin; Zecevic, Dusanka; Figueirido, Catarina; Wang, Qing; Giacobino, Caroline; Selmaj, Krzysztof; Cree, Bruce A. C.
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Understanding the Impact and Burden of Menopause on Multiple Sclerosis Through a Targeted Literature Review
Arliene Ravelo, Elmor Pineda, Ibraheem Abioye
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Association Between Socioeconomic Characteristics and Treatment Outcomes With Ocrelizumab in the CHIMES Trial of Black and Hispanic People With Multiple Sclerosis
Angel Chinea, Annette Okai, Anthony Reder, Bhupendra Khatri, Corey McGraw, David Jones, Dilraj Singh Sokhi, Evanthia Bernitsas, Faria Amjad, Gregory Wu, Ibraheem Abioye, Jugena Ndrio, Lawrence Goldstick, Lilyana Amezcua, Mitzi Williams, Nancy Monson
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Effectiveness and Safety of Ocrelizumab in Patients With Pediatric- Vs Young Adult–Onset Multiple Sclerosis: An MSBase Registry Matched Cohort Analysis
Anda Gershon, Corinne Manlius, Erwan Muros, Helmut Butzkueven, Tim Spelman
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Real-World Impact of Discontinuing Ocrelizumab on Healthcare Resource Utilization and Cost Among Older Adult Patients With Multiple Sclerosis in the United States
Achal Patel, Danny Sheinson, Elmor Pineda, Ibraheem Abioye, Zhiyu Xia
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Real-World Study of Ocrelizumab and Other Disease-Modifying Therapy Utilization and Disease Activity from Preconception through Postpartum in Women With MS
Arliene Ravelo, Danny Sheinson, Elmor Pineda, Erwan Muros, Maria Houtchens, Noemi Pasquarelli, Zhiyu Xia
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Charlotte, USA
Treatment Patterns of Ocrelizumab Subcutaneous: An Early Look Into Utilization in a Medicare Population With Multiple Sclerosis
Pineda, Elmor D.; Cellia, Johanna; Kardel, Peter;Sheetz, Caitlin; Abioye, Ibraheem
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:00 AM
Duration 20mins Room E216ABCD
Efficacy and Safety of Fenebrutinib Vs Teriflunomide In Relapsing Multiple Sclerosis: Results of the Fenhance 1 and 2 Studies
Nicholas, Jacqueline A.;Oh, Jiwon; Bar-Or, Amit; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; von Büdingen, Hans-Chrsitian; Decker-Palmer, Marquita; Loukitcheva, Anastasia; Triyatni, Miriam; Hu, Nan; Choi, Yoonha; Racthford, John N.; Napieralski, Julie; Goodyear, Alexandra; Kappos, Ludwig; Hauser, Stephen L.
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.